AMs recommend that pharmacists have access to palliative care data in Wales

AMs recommend that pharmacists have access to palliative care data in Wales

July 18 2018 Community pharmacists should be among those health professionals who are alerted to...

APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

July 18 2018 The Association of Pharmacy Technicians UK is questioning a survey on pharmacy...

Community pharmacy briefing for MPs due this week

Community pharmacy briefing for MPs due this week

July 16 2018 Community pharmacy organisations are due to brief MPs at Westminster on Tuesday 17...

GPhC asks for views on publication and disclosure policy update in light of GDPR

GPhC asks for views on publication and disclosure policy update in light of GDPR

July 10 2018 The General Pharmaceutical Council is seeking views on how its publication and...

CMO concludes cannabis products should move out of Schedule 1 classification

CMO concludes cannabis products should move out of Schedule 1 classification

July 9 2018 The Chief Medical Officer has recommended rescheduling cannabis-based products as...

  • AMs recommend that pharmacists have access to palliative care data in Wales

    AMs recommend that pharmacists have access to palliative care data in Wales

    Wednesday, 18 July 2018 17:41
  • APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

    APTUK questions claims about pharmacy technicians’ desire to supervise medicines supplies

    Wednesday, 18 July 2018 17:17
  • Community pharmacy briefing for MPs due this week

    Community pharmacy briefing for MPs due this week

    Monday, 16 July 2018 15:31
  • GPhC asks for views on publication and disclosure policy update in light of GDPR

    GPhC asks for views on publication and disclosure policy update in light of GDPR

    Tuesday, 10 July 2018 09:29
  • CMO concludes cannabis products should move out of Schedule 1 classification

    CMO concludes cannabis products should move out of Schedule 1 classification

    Monday, 09 July 2018 09:18

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

sunbatheMay 31 2016

Sun creams should not be able to use the terms ‘once-a-day’ or ‘eight-hour’, the consumer organisation Which? has said.

It has issued the warning after testing a number of sun cream products against duration claims made by manufacturers. It noted that there is no universal approach or standard that manufacturers have to adhere to. In addition to conducting its usual sun cream tests for sun protection factor claims, Which? also assessed SPF on subjects at the end of the period (six or eight hours) claimed for protection by the manufacturers. Subjects had worn a tee-shirt over the applied sun cream in the testing laboratory.

On testing the subjects at the end of the study period, there was a 74% decrease in SPF protection. “The reason for this reduction is probably the volunteer’s back rubbing against their t-shirt and the chair,” said Which?. In real life, in addition the sun cream rubbing off on the sun-lounger, towels, or tee-shirts, conditions would be even more likely to affect sun cream duration, due to factors such as heat, sweating or water.

The organisation said that duration claims are not allowed in Australia, “where anything that leads consumers to believe sun creams don’t need to be regularly reapplied is forbidden.” Based on its UK analysis, Which? added: “We’re not confident that one application of any sun cream will keep you adequately protected in the sun. Our concern is they may offer a false sense of security, exposing [users] to a greater risk of sunburn.”

Commenting on the findings, Professor Jayne Lawrence, the Royal Pharmaceutical Society’s Chief Scientist, said: “Our own survey into sunscreen use revealed a worrying lack of understanding about using it. Under half of those surveyed (44%) always or often used sunscreen when out in the sun and a third (31%) of those asked either did not know how much lotion to apply, or thought they should apply less than needed, to ensure protection.

“About three tablespoons (30 ml) of sunscreen is required to cover the average body of an adult to give the level of protection stated as the SPF on the bottle and this should be repeated every two hours. It’s also advisable to cover up with a t-shirt, sunglasses and hat during the hottest part of the day (11am-3pm) and find the shade where you can.”

Links:

Which? announcement

RPS comment

RP survey findings (June 2015)

Legal & Policy News

July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued.
July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued. The MHRA has launched the consultation with...